Evidence map›Paper›PMID 42775294›Full record

ArticleBioinformatics advances2026

ClinIAN: Clinically Informed Attention Network.

Florian König, Jonas C Ditz, Elham Shamsara, Pontus Hedberg, Iuri Fanti, Pontus Nauclér, Luca Carioti, Andreas Walker, Milosz Parczewski, Francis Drobniewski and 5 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Florian KönigInstitute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen 72076, Germany.ORCID https://orcid.org/0009-0003-5219-6383
Jonas C DitzInstitute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen 72076, Germany.
Elham ShamsaraInstitute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen 72076, Germany.
Pontus HedbergDivision of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm 17177, Sweden.ORCID https://orcid.org/0000-0003-3153-098X
Iuri FantiEuResist Network GEIE, Roma 00152, Italy.
Pontus NauclérDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm 17177, Sweden.
Luca CariotiDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.ORCID https://orcid.org/0000-0003-1713-8682
Andreas WalkerInstitute of Virology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf 40225, Germany.
Milosz ParczewskiDepartment of Tropical Infectious Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, Szczecin 70-204, Poland.
Francis DrobniewskiDepartment of Infectious Disease, Imperial College, London, W12 0NN, United Kingdom.
Francesca Ceccherini-SilbersteinDepartment of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, Siena 53100, Italy.
Björn-Erik Ole JensenDepartment of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf 40225, Germany.
Anders SönnerborgDivision of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm 17177, Sweden.
Nico PfeiferInstitute for Bioinformatics and Medical Informatics (IBMI), University of Tübingen, Tübingen 72076, Germany.ORCID https://orcid.org/0000-0002-4647-8566

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Artificial Neural Networks (ANNs) hold promise in predicting disease severity from viral protein sequences. To gain clinical insights, the models must adhere to two key factors: first, they need to be interpretable, as using black-box models within a healthcare setting poses risks, and second, they should integrate viral and clinical features to correct for biases within the data. We propose ClinIAN (Clinically Informed Attention Network), an inherently interpretable end-to-end learning model that effectively combines clinical and sequence parameters. We evaluate ClinIAN within the context of the challenging task of predicting the severity of SARS-CoV-2 infection, but it could be applied to other medical and biological contexts, with sequence and tabular features, such as bacterial infections or cancer research. Results: We evaluate the performance capabilities of ClinIAN in predicting SARS-CoV-2 severity using a subset of the EuCARE hospitalized cohort. We show ClinIAN's ability to capture biologically relevant features across multiple layers of resolution while retaining stable state-of-the-art performance. Availability and implementation: The code is available on Zenodo and on GitHub.

Identifiers

PMID42775294
PMCPMC13596770

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.